Spino Modulation

Spino Modulation Inc. is a subsidiary of Spinologics Inc. Spino Modulation is developing methods to treat idiopathic scoliosis (scoliosis of unknown cause) to reduce deformities and prevent deterioration in children/adolescents at high risk of curve progression, while allowing patients to maintain normal physical activity. Spino Modulation's product, the MIScoli System, is honored to be designated as a Breakthrough Device by the FDA.